Indiana officials on Thursday announced a nearly $75 million public–private investment aimed at strengthening literacy, STEM ...
TipRanks on MSN
Eli Lilly’s new study on LY4213663: A potential game-changer for rheumatoid arthritis?
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company is conducting a Phase ...
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. In a recent clinical study update, Eli ...
Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...
Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback